Physician profile
William A Thomas
NPI 1942202213
$2,427.70
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $604 · 2021: $1,347 · 2022: $166.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $574.34 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $417.17 | 2019-2021 | |
| Lilly USA, LLC | $223.06 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.14 | 2021-2022 | |
| Abbvie INC. | $101.53 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $99.20 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $76.27 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $66.95 | 2020-2021 | |
| Allergan, INC. | $66.12 | 2020 | |
| Amgen INC. | $64.43 | 2019-2020 | |
| Orexo US, INC. | $60.39 | 2019-2021 | |
| Pfizer INC. | $44.86 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $43.81 | 2019-2020 | |
| Antares Pharma, INC. | $41.93 | 2019-2021 | |
| Dexcom, INC. | $41.78 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $38.44 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $38.27 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $35.16 | 2019-2020 | |
| Gilead Sciences, INC. | $34.99 | 2020 | |
| Nevro Corp. | $32.74 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $25.84 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.95 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $20.63 | 2022 | |
| Glaxosmithkline, LLC. | $20.33 | 2021 | |
| Hologic Sales and Service, LLC | $16.99 | 2019 | |
| Astellas Pharma US INC | $16.47 | 2021 | |
| Indivior INC. | $16.22 | 2019 | |
| Dermira, INC. | $15.76 | 2020 | |
| Aytu Biopharma, INC. | $14.45 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.98 | 2021 | |
| Clarus Therapeutics INC. | $13.81 | 2021 | |
| Eisai INC. | $11.96 | 2020 | |
| Sanofi Pasteur INC. | $11.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.